Another synthetic triterpenoid CDDO-dhTFEA could restore NRF2 decrease in rat CKD by 5/6 nephrectomy, and attenuated kidney inflammation and fibrosis [213]. This evidence concerns the gene NFE2L2 and chronic kidney disease.